HT Warning Removal May Expand Use in Rheumatic Disease Care



Given the FDA’s decision to initiate the removal of boxed warning labels from hormone therapy products, it may be prescribed more often to menopausal women with rheumatic disease.
Medscape Medical News



Source link : https://www.medscape.com/viewarticle/hormone-therapy-boxed-warning-removal-may-expand-its-use-2026a10000r7?src=rss

Author :

Publish date : 2026-01-09 12:46:00

Copyright for syndicated content belongs to the linked Source.
Exit mobile version